Correlation Between Acarix AS and Clinical Laserthermia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acarix AS and Clinical Laserthermia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acarix AS and Clinical Laserthermia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acarix AS and Clinical Laserthermia Systems, you can compare the effects of market volatilities on Acarix AS and Clinical Laserthermia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acarix AS with a short position of Clinical Laserthermia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acarix AS and Clinical Laserthermia.

Diversification Opportunities for Acarix AS and Clinical Laserthermia

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Acarix and Clinical is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Acarix AS and Clinical Laserthermia Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clinical Laserthermia and Acarix AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acarix AS are associated (or correlated) with Clinical Laserthermia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clinical Laserthermia has no effect on the direction of Acarix AS i.e., Acarix AS and Clinical Laserthermia go up and down completely randomly.

Pair Corralation between Acarix AS and Clinical Laserthermia

Assuming the 90 days trading horizon Acarix AS is expected to generate 0.6 times more return on investment than Clinical Laserthermia. However, Acarix AS is 1.66 times less risky than Clinical Laserthermia. It trades about 0.03 of its potential returns per unit of risk. Clinical Laserthermia Systems is currently generating about -0.01 per unit of risk. If you would invest  30.00  in Acarix AS on August 24, 2024 and sell it today you would earn a total of  2.00  from holding Acarix AS or generate 6.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Acarix AS  vs.  Clinical Laserthermia Systems

 Performance 
       Timeline  
Acarix AS 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Acarix AS are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Acarix AS sustained solid returns over the last few months and may actually be approaching a breakup point.
Clinical Laserthermia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clinical Laserthermia Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Acarix AS and Clinical Laserthermia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acarix AS and Clinical Laserthermia

The main advantage of trading using opposite Acarix AS and Clinical Laserthermia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acarix AS position performs unexpectedly, Clinical Laserthermia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clinical Laserthermia will offset losses from the drop in Clinical Laserthermia's long position.
The idea behind Acarix AS and Clinical Laserthermia Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Managers
Screen money managers from public funds and ETFs managed around the world